Extracorporeal shock wave therapy in equine and canine practice.

ESWT effectively treats tendon, ligament, and bone injuries; avoid NSAIDs and cryotherapy during treatment.

Extracorporeal shock wave therapy (ESWT) is a non-invasive therapeutic modality that stimulates tissue healing through microtrauma-induced release of anti-inflammatory cytokines and growth factors. This review describes the mechanism of action and clinical applications of ESWT in equine and canine practice. Electrohydraulic and piezoelectric shock wave systems are most commonly utilized in veterinary medicine for treating tendon and ligament injuries, osteoarthritis, and nonunion fractures. Treatment efficacy depends on adjustable parameters including depth, energy level, and pulse number. ESWT demonstrates particular utility at enthesopathic sites where different tissue types interface, such as bone-soft tissue junctions, where maximum energy deposition occurs. Critical management considerations include avoiding concurrent anti-inflammatory medications and cryotherapy, as these may compromise the therapeutic mechanism. Post-treatment rest for 48 hours is recommended to prevent further tissue damage while capitalizing on the potent analgesic effects. Practitioners must ensure compliance with competition regulations regarding ESWT use and provide appropriate client education. ESWT represents an accessible, evidence-supported treatment option for musculoskeletal conditions in veterinary practice.

This summary was distilled by AI and may occasionally misinterpret data. Confirm critical details with the primary literature before clinical application.